Theseus Pharmaceuticals, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four in USD from Q3 2021 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Theseus Pharmaceuticals, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four history and growth rate from Q3 2021 to Q4 2022.
  • Theseus Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending December 31, 2022 was $846K, a 2.3% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Four, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $846K +$19K +2.3% Dec 31, 2022 10-K 2023-03-09
Q3 2022 $846K +$43K +5.36% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $846K Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $821K Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $827K Dec 31, 2021 10-K 2022-03-10
Q3 2021 $803K Sep 30, 2021 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.